Hypomorphic homozygous mutations in phosphoglucomutase 3 (PGM3) impair immunity and increase serum IgE levels.

MLA

Sassi, Atfa, et al. “Hypomorphic Homozygous Mutations in Phosphoglucomutase 3 (PGM3) Impair Immunity and Increase Serum IgE Levels.” The Journal of Allergy and Clinical Immunology, vol. 133, no. 5, May 2014, pp. 1410–19. EBSCOhost, https://doi.org/10.1016/j.jaci.2014.02.025.

APA

Sassi, A., Lazaroski, S., Wu, G., Haslam, S. M., Fliegauf, M., Mellouli, F., Patiroglu, T., Unal, E., Ozdemir, M. A., Jouhadi, Z., Khadir, K., Ben-Khemis, L., Ben-Ali, M., Ben-Mustapha, I., Borchani, L., Pfeifer, D., Jakob, T., Khemiri, M., Asplund, A. C., … Grimbacher, B. (2014). Hypomorphic homozygous mutations in phosphoglucomutase 3 (PGM3) impair immunity and increase serum IgE levels. The Journal of Allergy and Clinical Immunology, 133(5), 1410–1419. https://doi.org/10.1016/j.jaci.2014.02.025

Chicago

Sassi, Atfa, Sandra Lazaroski, Gang Wu, Stuart M Haslam, Manfred Fliegauf, Fethi Mellouli, Turkan Patiroglu, et al. 2014. “Hypomorphic Homozygous Mutations in Phosphoglucomutase 3 (PGM3) Impair Immunity and Increase Serum IgE Levels.” The Journal of Allergy and Clinical Immunology 133 (5): 1410–19. doi:10.1016/j.jaci.2014.02.025.